For years, the suffering of long COVID patients was mapped onto a familiar biological story: inflammation, the body turning against itself, the brain caught in a smoldering fire. A new Finnish imaging study gently dismantles that narrative, finding no widespread neuroinflammation in long COVID patients, but instead discovering heightened activity in the brain's emotional centers — the hippocampus and amygdala — among those most severely affected. The finding does not diminish the reality of the illness, but it shifts the question from 'what is burning?' to 'what is the brain struggling to carr
Brain scans challenge inflammation theory in long COVID, point to emotional dysregulation
Long COVID affects millions worldwide with symptoms persisting months or years, impacting quality of life through fatigue, cognitive impairment, anxiety, and depression.
Inflammation may be strongest right after infection and diminish over time
Mark
So the inflammation theory was wrong?
Mimi
Not entirely wrong—it just wasn't the whole story. Early in infection, there does seem to be inflammation. But by the time most long COVID patients are scanned, months or years later, that inflammation has largely cleared.
Luke
How confident are we in that? The study is 14 patients. That's a real limitation.
Mimi
True. It's a small sample. But they used rigorous imaging techniques and included MS patients as a positive control, which strengthens the methodology.
Mark
What about the emotional dysregulation finding? Is that saying it's all in people's heads?
Mimi
No. The increased activity in the hippocampus and amygdala is a measurable brain change. It's not imagined. But it's different from inflammation—it's about how the brain processes emotion and stress.
Luke
And we know that increased activity in those regions correlates with depression and anxiety. But correlation isn't causation. Does the brain activity cause the symptoms, or do the symptoms cause the brain activity?
Mimi
That's the open question. The study can't answer that with certainty.
Mark
So what changes for patients now?
Mimi
The researchers suggest shifting away from anti-inflammatory drugs and toward therapies that help with emotional regulation and stress management.
Luke
But those therapies already exist, and they're not a cure-all for long COVID. This finding doesn't guarantee they'll work better than what's being tried now.
Mimi
No, it doesn't. But it reframes where to look, which is valuable for research moving forward.
Der Puls
- Millions living with long COVID have waited years for a biological explanation that might unlock effective treatment — and the leading inflammation theory has now been called into serious doubt by brain imaging evidence.
- PET and MRI scans of long COVID patients revealed no meaningful neuroinflammation compared to healthy controls, a finding that contradicts assumptions quietly embedded in clinical thinking and research funding alike.
- A subtle but important clue emerged: patients scanned within 16 months of infection showed more white matter inflammatory activity than those further out, suggesting inflammation may burn early and then retreat, leaving something else behind.
- What remains appears to live in the emotional brain — the hippocampus and amygdala showed heightened cellular activity in patients with the most severe depression, anxiety, and diminished quality of life.
- Researchers are now pointing treatment strategies away from anti-inflammatory drugs and toward psychological and stress-regulation interventions, a pivot that reframes long COVID not as a disease of immune fire, but of emotional dysregulation.
- The study does not close the case on long COVID — it reopens it along a different corridor, one where the brain's capacity to process suffering may matter as much as any inflammatory marker in the blood.
For years, the suffering of long COVID patients was mapped onto a familiar biological story: inflammation, the body turning against itself, the brain caught in a smoldering fire. A new Finnish imaging study gently dismantles that narrative, finding no widespread neuroinflammation in long COVID patients, but instead discovering heightened activity in the brain's emotional centers — the hippocampus and amygdala — among those most severely affected. The finding does not diminish the reality of the illness, but it shifts the question from 'what is burning?' to 'what is the brain struggling to carry?' and with it, the search for healing moves toward the architecture of emotion rather than the machinery of immune suppression.
For years, the working theory behind long COVID's most stubborn symptoms — the unrelenting fatigue, the cognitive fog, the anxiety and depression — pointed toward inflammation quietly persisting inside the brain. It was a tidy hypothesis, one that implied a biological culprit and a potential treatment path. A new study from the University of Turku in Finland has complicated that picture considerably.
Using advanced PET imaging designed to detect neuroinflammation, alongside structural MRI and blood biomarkers, Finnish researchers compared 14 long COVID patients against 11 healthy controls and 13 patients with multiple sclerosis — a disease where brain inflammation is well-documented and measurable. The results were striking: long COVID patients showed no meaningful signs of widespread brain inflammation relative to healthy individuals. Their inflammatory activity in white matter was, in fact, significantly lower than that observed in MS patients.
One nuance emerged from the data. Patients scanned within 16 months of their initial infection showed somewhat higher white matter inflammatory activity than those further removed from illness, hinting that inflammation may be a feature of early COVID-19 and its immediate aftermath rather than the persistent engine driving symptoms months or years later.
If inflammation is not the primary culprit, the study offers a different answer: emotional dysregulation. Among patients with the most severe depression, anxiety, and lowest quality of life, researchers found heightened cellular activity in the hippocampus and amygdala — the brain's centers for mood, memory, and stress processing. The more severe the symptoms, the more active these regions appeared.
The treatment implications are meaningful. Rather than anti-inflammatory drugs, the researchers suggest that therapies targeting emotional regulation and stress management may prove more effective for many long COVID patients. This is not a claim that the illness is psychological in origin — the study makes no such argument. It is, rather, a finding that the biological pathway to suffering in long COVID may run through the brain's emotional architecture, not through immune activation in tissue.
Long COVID continues to affect millions worldwide, with symptoms persisting for months or years and disrupting work, relationships, and daily life. This study does not resolve the disease's complexity, but it meaningfully redirects the search — toward a more layered understanding of how the brain carries the weight of prolonged illness.
For years, researchers have suspected that long COVID's stubborn symptoms—the fatigue that won't lift, the fog that clouds thinking, the anxiety and depression that settle in—might stem from persistent inflammation smoldering inside the brain. It was a plausible theory, one that pointed toward a clear biological culprit and suggested a clear path to treatment. But a new imaging study from Finland has upended that assumption, finding instead that the brains of long COVID patients look remarkably similar to those of healthy people when it comes to inflammatory markers.
Scientists at the University of Turku used advanced PET imaging designed to detect neuroinflammation, along with MRI scans to examine brain structure and white matter. They studied 14 people with long COVID, compared them to 11 healthy controls, and included 13 patients with multiple sclerosis as a reference group—MS being a disease where brain inflammation is well-established and measurable. Blood work was also drawn to look for biomarkers of neuronal and glial damage. What they found was striking: long COVID patients showed no meaningful signs of widespread brain inflammation when measured against the healthy group. In fact, their inflammatory activity in white matter was significantly lower than what appeared in the MS patients.
Laura Airas, the neuroimmunologist who led the work, stated plainly that the team observed no evidence of widespread brain inflammation in long COVID patients compared to healthy controls. This finding challenges a hypothesis that has circulated through the research community and shaped how some clinicians think about the disease. Yet the picture is not entirely clean. Patients scanned within 16 months of their initial infection showed higher white matter inflammatory activity than those further out from infection, suggesting that inflammation may flare early and then recede as time passes. The implication is that brain inflammation might be a feature of acute COVID-19 and the immediate aftermath, but not the persistent driver of long COVID symptoms months or years later.
If inflammation is not the answer, what is? The study points toward emotional dysregulation. Patients with the most severe depression, anxiety, and lowest quality of life showed increased cellular activity in two regions: the hippocampus and the amygdala. These are the brain's emotional command centers, involved in memory formation, mood regulation, and the processing of stress. The stronger the symptoms, the more active these regions became. This suggests that the neurological signature of long COVID may not be inflammatory at all, but rather a disruption in how the brain manages emotion and stress.
The implications for treatment are significant. If long COVID is not primarily an inflammatory disease of the brain, then drugs designed to suppress inflammation may not be the answer for many patients. Instead, the researchers propose that therapies targeting stress and emotional regulation—psychological interventions, perhaps, or approaches that help patients manage the emotional weight of persistent illness—might prove more effective. This is not to say long COVID is psychological in origin; the study does not suggest that. Rather, it indicates that the biological pathway to symptom severity runs through emotional processing, not through immune activation in brain tissue.
Long COVID remains a condition of enormous scope, affecting millions of people worldwide. Symptoms can persist for months or years, leaving people unable to work, unable to exercise, unable to live as they did before infection. The disease is real, the suffering is real, and the need for effective treatment is urgent. This study does not solve the puzzle of long COVID, but it redirects the search. It suggests that researchers and clinicians should look not just at inflammation, but at the brain's emotional architecture, and that future treatments may need to address both the biological and psychological dimensions of a disease that has proven far more complex than early theories suggested.
Bemerkenswerte Zitate
We did not observe evidence of widespread brain inflammation in patients with long COVID when compared to healthy controls— Laura Airas, Professor of Neuroimmunology, University of Turku
Patients with prolonged symptoms may benefit more from treatments targeting stress and emotional regulation rather than therapies aimed solely at reducing inflammation— Research team findings
Möchten Sie die ganze Geschichte?
Das Original lesen bei News-Medical.net ↗
Health & Medicine